Compounds > gadolinium dtpa
Page last updated: 2024-09-04

gadolinium dtpa and Cystadenocarcinoma, Serous

gadolinium dtpa has been researched along with Cystadenocarcinoma, Serous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayasaka, T; Kawagoe, J; Kojimahara, T; Kurachi, H; Motoyama, T; Nakahara, K; Ohmichi, M; Ohta, T; Saitoh, M1
Batchelor, EC; Jenrette, JM; Watkins, JM1

Other Studies

2 other study(ies) available for gadolinium dtpa and Cystadenocarcinoma, Serous

ArticleYear
Characteristic features of ovarian borderline tumors with invasive implant.
    Archives of gynecology and obstetrics, 2005, Volume: 272, Issue:4

    Topics: Adult; Contrast Media; Cystadenocarcinoma, Serous; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Ovarian Neoplasms

2005
Definitive radiotherapy for medically inoperable early-stage serous and clear cell uterine carcinoma.
    Radiation medicine, 2007, Volume: 25, Issue:10

    Topics: Aged; Contrast Media; Cystadenocarcinoma, Serous; Dose Fractionation, Radiation; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Radiotherapy Dosage; Sarcoma, Clear Cell; Uterine Neoplasms

2007